Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 
 
 

FDA awards Absorption Systems Phase I SBIR Grant for CellPort Technologies
March 2009
SHARING OPTIONS:

EXTON, Pa.—The U.S. Food and Drug Administration (FDA) has awarded Absorption Systems LP a Small Business Innovation Research (SBIR) Phase I grant to develop an innovative tool to help determine the potential for drug-drug interactions. Absorption Systems will use the $215,000 Phase I grant to further develop the company's CellPort Technologies assay system, a suite of preclinical in vitro test systems designed to provide definitive data regarding interactions between new drugs under investigation and specific transporter proteins that have been identified by the FDA as key indicators of drug safety. The current suite of CellPort Technologies test systems includes assays for three different human drug efflux transporters. The company plans to apply later this year for a follow-on Phase II SBIR grant, providing up to $750,000 over two years.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.